News

Vietnam Investment Review on MSN1h
Innovent begins phase 3 GLORY OSA trial for mazdutide in China
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Onlymyhealth17h
Can Ozempic Lower the Risk of Heart Diseases Within the First 6 Months? Expert Weighs In
The doctor tells how Ozempic might be a new boon for treating heart health problems like strokes heart attack etc ...
Center for Biosimilars21h
Biosimilar Misconceptions, PBM Transparency, and Value-Based Care: Insights from Canavan & O'Dell
Josh Canavan, PharmD, RazorMetrics, and Chris O'Dell, Turquoise Health, explain the misconception that cheaper biosimilars automatically lead to lower costs due to pharmacy benefit manager (PBM) ...
North Country Public Radio21h
Advice for trying GLP-1 drugs for weight loss from a doctor who's been there
Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...